236(top 1%)
papers
7.5K(top 1%)
citations
48(top 1%)
h-index
75(top 1%)
g-index
244
all documents
7.7K
doc citations
1.9K
citing journals

Top Articles

#TitleJournalYearCitations
1Betaine Improves the PCR Amplification of GC-Rich DNA SequencesNucleic Acids Research1997440
2Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: Diagnostic and prognostic implicationsInternational Journal of Cancer2004195
3Laparoscopic Radical ProstatectomyEuropean Urology2001193
4LAPAROSCOPIC RADICAL CYSTECTOMY WITH CONTINENT URINARY DIVERSION (RECTAL SIGMOID POUCH) PERFORMED COMPLETELY INTRACORPOREALLY: THE INITIAL 5 CASESJournal of Urology2001190
5Urodynamic results and clinical outcomes with intradetrusor injections of onabotulinumtoxina in a randomized, placebo‐controlled dose‐finding study in idiopathic overactive bladderNeurourology and Urodynamics2011137
6Laparoscopic Radical Prostatectomy - the Experience of the German Laparoscopic Working GroupEuropean Urology2006131
7Comparison of Eight Computer Programs for Receiver-Operating Characteristic AnalysisClinical Chemistry2003122
8Different mRNA and Protein Expression of Matrix Metalloproteinases 2 and 9 and Tissue Inhibitor of Metalloproteinases 1 in Benign and Malignant Prostate TissueEuropean Urology2002121
9Hepsin is Highly Over Expressed in and a New Candidate for a Prognostic Indicator in Prostate CancerJournal of Urology2004117
10Evaluation of Magnetic Fluid Hyperthermia in a Standard Rat Model of Prostate CancerJournal of Endourology2004115
11High-dose rate interstitial with external beam irradiation for localized prostate cancer – results of a prospective trialRadiotherapy and Oncology1998113
12Diagnosis of bladder carcinoma using protoporphyrin IX fluorescence induced by 5‐aminolaevulinic acidBJU International1999110
13Blood specimen collection methods influence the concentration and the diagnostic validity of matrix metalloproteinase 9 in bloodClinica Chimica Acta2001106
14Rapid separation of serum does not avoid artificially higher matrix metalloproteinase (MMP)-9 levels in serum versus plasmaClinical Biochemistry2007104
15Vascular endothelial growth factor and its correlation with angiogenesis and p53 expression in prostate cancerProstate2000100
16Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissueUrology200099
17Genitourinary tuberculosisCurrent Opinion in Urology200199
18Tumor angiogenesis is associated with progression after radical prostatectomy in pT2/pT3 prostate cancer200093
19Sandwich enzyme immunoassay of cystatin C in serum with commercially available antibodiesClinical Chemistry199392
20Increased cell-free DNA in plasma of patients with metastatic spread in prostate cancerCancer Letters200492
21Solid organ transplantation programs facing lack of empiric evidence in the COVID-19 pandemic: A By-proxy Society Recommendation Consensus approachAmerican Journal of Transplantation202091
22Diagnostic sensitivity of serum cystatin for impaired glomerular filtration ratePediatric Nephrology199988
23The influence of prostate volume on the ratio of free to total prostate specific antigen in serum of patients with prostate carcinoma and benign prostate hyperplasiaCancer199785
24Quantitative analysis of macrophage inhibitory cytokine-1 (MIC-1) gene expression in human prostatic tissuesBritish Journal of Cancer200384
25Cathepsins B, H, L and cysteine protease inhibitors in malignant prostate cell lines, primary cultured prostatic cells and prostatic tissueEuropean Journal of Cancer199981
26Excretion of matrix metalloproteinases 2 and 9 in urine is associated with a high stage and grade of bladder carcinomaUrology200179
27Molecular, cellular and developmental biology of urothelium as a basis of bladder regenerationDifferentiation200574
28Prostate-specific antigen, its molecular forms, and other kallikrein markers for detection of prostate cancerUrology200272
29Management of Lymphoceles After Renal Transplantation: Laparoscopic Versus Open DrainageJournal of Urology200371
30Expression of the normal epithelial cell-specific 1 (NES1; KLK10) candidate tumour suppressor gene in normal and malignant testicular tissueBritish Journal of Cancer200170
31Diagnosing Cancer in VivoScience200169
32An artificial neural network to predict the outcome of repeat prostate biopsiesUrology200369
33RATIO OF FREE-TO-TOTAL PROSTATE SPECIFIC ANTIGEN IN SERUM CANNOT DISTINGUISH PATIENTS WITH PROSTATE CANCER FROM THOSE WITH CHRONIC INFLAMMATION OF THE PROSTATEJournal of Urology199868
34Detection of Human Kallikrein 4 in Healthy and Cancerous Prostatic Tissues by Immunofluorometry and ImmunohistochemistryClinical Chemistry200267
35The new synthetic matrix metalloproteinase inhibitor (Roche 28-2653) reduces tumor growth and prolongs survival in a prostate cancer standard rat modelOncogene200266
36Antioxidant Enzymes In Malignant Prostate Cell Lines and In Primary Cultured Prostatic CellsFree Radical Biology and Medicine199765
37Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissuesProstate200264
38Botulinum neurotoxin type A in urology: Antibodies as a cause of therapy failureInternational Journal of Urology200864
39Sirolimus delays recovery of rat kidney transplants after ischemia-reperfusion injuryTransplantation200362
40Analytical performance and clinical validity of two free prostate-specific antigen assays comparedClinical Chemistry199661
41Analytical Aspects Regarding the Measurement of Metalloproteinases and Their Inhibitors in BloodClinical Biochemistry199759
42Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissuesProstate200359
43Developmental changes of antioxidant enzymes in kidney and liver from ratsFree Radical Biology and Medicine199657
44Matrix metalloproteinases 1 and 3, tissue inhibitor of metalloproteinase-1 and the complex of metalloproteinase-1/tissue inhibitor in plasma of patients with prostate cancer199757
45Factors influencing the ratio of free to total prostate-specific antigen in serum199757
46LAPAROSCOPIC LIVE DONOR RIGHT NEPHRECTOMY: A NEW TECHNIQUE WITH PRESERVATION OF VASCULAR LENGTHJournal of Urology200257
47Molecular Cloning of a Novel Human Acid Phosphatase Gene (ACPT) That Is Highly Expressed in the TestisGenomics200153
48Matrix-metalloproteinases and their inhibitors in plasma and tumor tissue of patients with renal cell carcinomaInternational Journal of Cancer200052
49Laparoscopic anatrophic nephrolithotomyScandinavian Journal of Urology and Nephrology200451
50LAPAROSCOPIC RADICAL CYSTECTOMY WITH CONTINENT URINARY DIVERSION (RECTAL SIGMOID POUCH) PERFORMED COMPLETELY INTRACORPOREALLY:Journal of Urology200150